OPTOMED — Optomed Oyj Cashflow Statement
0.000.00%
Last trade - 00:00- €59.79m
- €52.60m
- €17.10m
Annual cashflow statement for Optomed Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.25 | -5.47 | -4.44 | -5.45 | -6.64 |
| Depreciation | |||||
| Non-Cash Items | 0.456 | -0.275 | 0.664 | 0.066 | 0.855 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.84 | 0.232 | 0.968 | 1.29 | 0.787 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.94 | -2.37 | -0.616 | -1.6 | -2.48 |
| Capital Expenditures | -2.57 | -3.03 | -2.41 | -2.12 | -2.36 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -2.57 | -3.03 | -2.41 | -2.12 | -2.36 |
| Financing Cash Flow Items | — | -0.682 | -0.318 | -0.554 | -0.418 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.64 | 7 | 1.61 | 7.08 | 4.19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.8 | 1.72 | -1.41 | 3.35 | -0.558 |